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1. Introduction
  There is a continuous and urgent need to discover new 
antimicrobial compounds with diverse chemical structures 
and novel mechanisms of action because there has been 
an alarming increase in the incidence of new and re-
emerging infectious diseases, appearance of undesirable 
side effects of certain antibiotics, as well as the increasing 
development of resistance to the antibiotics in current 
clinical use[1]. Therefore, actions must be taken to control 
the use of antibiotic, to better understand the genetic 
mechanisms of resistance, and to continue studies of 
developing new drugs. There are different approaches to 
cure and control the infection caused by the multidrug-
resistant (MDR) strains of bacteria, one of which is by 
isolation of active phytochemicals that can help to prevent 
the spread of infection. Another method is to formulate 
new synergistic combinations using different commercially 
available antibiotics, or to combine an antibiotic with 
active phytochemicals that have antimicrobial properties. 
Several in vitro studies have reported synergistic effects 
with significant reduction in the minimum inhibitory 
concentrations (MIC) of the antibiotics, resulting from 
the combination of different antibiotics with different 
crude plant extracts against Staphylococcus aureus (S. 
aureus) strains[2-7], and emerge as the real sources of 
potential resistance modifying agents[8,9]. In addition to 
that, synergistic effects have been reported against Gram-
negative bacteria [10-15]. The ability of plant extracts to 
potentiate antibiotics has not been well explained. It is 
predicted that inhibition of drug efflux, and alternative 
mechanisms of action could be responsible for the 
synergistic interactions between plant extracts and 
antibiotics [16,17]. 
  Pseudomonas aeruginosa (P. aeruginosa) causes 
nosocomial infections as a result of its ubiquitous nature, 
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ability to survive in moist environments, and resistance to 
many antibiotics and antiseptics. A main problem is the 
emergence of multidrug-resistant P. aeruginosa strains 
resistant to different antimicrobial agent classes. Infections 
caused by this microorganism are often severe, life 
threatening and difficult to be treated because of the high 
frequency of antibiotic resistance during therapy[18]. This 
high degree multidrug resistance may relate to the presence 
of antibiotic efflux systems which provide resistance to 
multiple antimicrobial agents [19].
  There is little data on synergy between extracts of Rhus 
coriaria (R. coriaria), Sacropoterium spinosum (S. spinosum ), Rosa 
damascena (R. damascena) and antibiotics[7,20]. The purpose 
of the present work was to establish synergy between 
ethanolic plant extracts of Rhus coriaria (R. coriaria) (seed), 
Sacropoterium spinosum(S. spinosum) (seed), and Rosa 
damascena (R. damascena) (flower) and certain known 
antimicrobial drugs such as oxytetracycline HCl, penicillin 
G, cephalexin, sulfadimethoxine as sodium, and enrofloxacin 
using microdilution method against 3 multidrug-resistant 
P. aeruginosa strains; thereby, throw light on the potential 
role of the phytochemicals in increasing the effectiveness of 
antibiotics.  
2. Materials and methods
2.1. Plant material and extract preparation
 The plant materials used in this study consisted of R. 
coriaria (seed), S. spinosum (seed), and R. damascena 
(flower), which are growing in Palestine. The fresh plant 
materials were dried in open air protected from direct 
exposure to sunlight. Approximately 30-50 g of dried plant 
materials was separately powdered, and extracted with 200-
300 mL of 80% ethanol as describe previously[21]. Extracts 
were filtered through Whatman No. 2 filter paper under 
vacuum and concentrated to dryness at 37 曟. Then, 100 mg 
of the dry residue was dissolved in 1 mL of sterile distilled 
water.
2.2. Bacterial strains
  Three strains of multidrug-resistant P. aeruginosa were 
isolated from clinical samples (urine, surgical wound, 
and ear swab) have been used in this study. These 
strains were resistant to different antibiotics such as 
ampicillin, cefuroxime, cefotaxime, gentamicin, amikacin, 
erythromycin, clindamycin, ofloxacin, nalidixic acid, 
norfloxacin, ciprofloxacin and amoxicillin-clavulanic. In 
addition, Bacillus subtilis ATCC 6633 was included as a 
reference strain. 
2.3. Antimicrobial drugs
  Five drugs were evaluated for synergism assays 
including oxytetracycline HCl (10%), enrofloxacin (10%), 
sulfadimethoxine as sodium (40%), cephalexin (0.15%) 
and penicillin G (penicillin G procaine 900 000 and 
penicillin G sodium 300 000 U). All these drugs were 
produced by Jerusalem Pharmaceutical CO. Balsam branch 
except penicillin G was produced by Birzeit-Palestine 
Pharamaceutical Co. These drugs were diluted to a final 
concentration of 200 U/mL for penicillin G; 50 毺g/mL for 
oxytetracycline HCl, cephalexin and enrofloxacin; and 100 毺g/mL 
for sulfadimethoxine.
2.4. Antimicrobial tests
  Minimum inhibitory concentration (MIC) of antibiotics as 
well as plant extracts were determined by the microdilution 
method as described by Clinical and Laboratory Standards 
Institute (formerly the National Committee for Clinical 
Laboratory Standards, NCCLS) [22]. The antibiotic was 
serially diluted in Mueller Hinton broth. Plant extracts 
solution were separately added into wells in a final 
concentration of 1.5 mg/mL, then bacterial inoculum size of 
105 CFU/mL was added to each well. Controls without plant 
extracts, without bacterial inoculum or with plant extracts 
only were also included in the experiment. Each plant 
extract was run in duplicate. The test plates were incubated 
at 37 曟 for 18 h. The MIC was taken as the minimum 
concentration of the dilutions that inhibited the growth of 
the test microorganism. For bactericidal activity detection, 
100 毺L were spread on agar plate and incubated at 37 曟
for 18 h.
3. Results
  Our results showed that there is a decrease in the MIC 
in case of combination between ethanolic plant extracts of 
R. coriaria, S. spinosum, and R. damascena and different 
antimicrobial agents (oxytetracycline HCl, penicillin G, 
cephalexin, sulfadimethoxine as sodium, and enrofloxacin) 
against 3 test strains of P. aeruginosa using microdilution 
method. This implies that these plant extracts increased 
the antibacterial activity of the antibiotics against the test 
strains of P. aeruginosa, and showed synergistic interaction. 
The most interesting result is shown by the combination 
between R. coriaria and these antibiotics, which showed 
a high decrease in MIC, and a strong bactericidal activity 
against these strains. Minimum fold reduction of inhibitory 
concentration and change in MIC of antimicrobial agents are 
presented in Table 1.
4. Discussion
  Many studies have shown that active efflux can be a 
mechanism of resistance for almost all antibiotics[23]. The 
majority of the efflux systems in bacteria are non-drug-
specific proteins that can recognize and export a broad 
range of chemically and structurally unrelated compounds 
from bacteria without drug alteration or degradation[24]. 
Antibiotic efflux is a major mechanism of antibiotic 
resistance in P. aeruginosa due to Mex efflux proteins. 
Resistance to 毬–lactams and non- 毬-lactam antibiotics 
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has been attributed to efflux by the MexAB-OprM pump[25]. 
Other Mex efflux proteins mediating multidrug resistance 
have also been identified in P. aeruginosa[26]. Efflux pump 
inhibitors combined with antibiotics strategy is an effective 
way to solve the problem caused by resistant bacteria[27]. The 
majority of plant derived antimicrobial compounds generally 
have higher MICs than bacterial or fungal produced 
antibiotics, thus limiting their therapeutic potential[28]. 
  The plant extracts tested in this study, especially R. 
coriaria extract with oxytetracycline HCl, penicillin G, 
cephalexin, sulfadimethoxine as sodium, or enrofloxacin 
showed a powerful bactericidal activity to three test strains 
of P. aeruginosa and combinations have obvious synergistic 
activity. These results may indicate that R. coriaria extract 
contain natural inhibitors working by different mechanisms 
or inhibiting efflux pumps. 
  In conclusion, the results of this study were encouraging, 
although clinical controlled studies are needed to define the 
real efficacy and possible toxic effects in vivo. However, it 
is hard to predict synergistic effects in vivo on the basis of 
the presented in vitro evidence alone because it is difficult 
to estimate the in vivo concentration of active ingredients. 
Now we have experiments underway leading to the 
identification of the active molecules present in R. coriaria. 
Here we recommended the evaluation of the exact drug-
plant ratio at which the interaction in maximal between 
the plant extract and antimicrobial drug. A wider study 
with increase in the number of drugs, increase number of 
clinical isolates, are also necessary in order to establish 
the mode of action against the P. aeruginosa isolates 
and the mechanism of synergy, which is fundamental to 
development of pharmacological agents to treat diseases by 
Table 1 
Minimum inhibitory concentration of antibiotics alone, plant extracts alone,   and in combination against 3 clinical isolates of P. aeruginosa using 
microdilution method.
      
Antibiotic a/plant extrat
MIC (毺g/mL) 
b
Minimum fold reduction of
 inhibitory concentrationStrain 1 Strain 2 Strain 3
R. coriaria 3.125 伊 103 (3.125-1.563) 伊 103 1.563 伊 103
S. spinosum    6.5 伊103       (12.5-6.5) 伊 103    12.5 伊 103
R. damascene      25 伊 103        (25-12.5) 伊 103    12.5 伊 103
ENR >25 >25 >25
R. coriaria + ENR <0.012 2 <0.012 2 <0.012 2 >2 000
S. spinosum + ENR 1.563 0.390 0.195 >64
R. damascene + ENR 3.125 3.125 3.125 >64
OT >25 >25 >25
R. coriaria + OT <0.024 4 <0.024 4 <0.024 4 >1 024
S. spinosum + OT 6.25 6.25 <0.024 4 >4
R. damascene + OT 6.25 6.25 6.25 >4
CL >25 >25 >25
R. coriaria + CL <0.012 2 <0.012 2 <0.012 2 >2 000
S. spinosum +CL 0.048 8 0.195 0 1.563 0 >16
R. damascene CL 0.048 8 0.195 0 1.563 0 >16
P (Unit) >100 >100 >100
R. coriaria + P <0.048 8 <0.048 8 <0.048 8 >2 000
S. spinosum + P 12.500 1.563 0.195 >8
R. damascene + P 12.500 3.125 1.563 >8
SDM >50 >50 >50
R. coriaria + SDM <0.195 0-0.097 7 <0.024 4 <0.024 4 >256
S. spinosum + SDM 6.250 0 6.250 0 <0.024 4 >8
R. damascene + SDM 6.250 0.780 3.125 >8
aP, Penicillin G; CL, Cephalexin;  SDM, sulfadimethoxine as sodium; ENR, Enrofloxacin; OT, Oxytetracycline HCl. bConcentration of penicillin 
G in units (U).
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P. aeruginosa using medicinal plants. Our results revealed 
that the combined use of plant extracts and antibiotics could 
be useful in fighting emerging drug-resistance problem and 
in vivo experiments are needed to confirm pseudomonal 
protection using these combinations.
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